Not checked for notices yet.
Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial
Richard G. Wunderink, Evangelos J. Giamarellos-Bourboulis, Galia Rahav and 20 more
Infectious Diseases and Therapy · 2018
Cited by papers we hold 6
- Antibiotic resistance breakers: current approaches and future directions · 2019No notice
- Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options · 2019No notice
- Treatment Options for Colistin Resistant Klebsiella pneumoniae: Present and Future · 2019No notice
- Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections · 2019No notice
- Treatment of Infections Due to MDR Gram-Negative Bacteria · 2019No notice
- The “Old” and the “New” Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How · 2019No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.